Bill Maughan
Stock Analyst at Clear Street
(0.69)
# 4,009
Out of 5,146 analysts
21
Total ratings
35.71%
Success rate
-19.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Upgrades: Buy | $10 → $18 | $12.14 | +48.27% | 2 | Feb 19, 2026 | |
| CRBU Caribou Biosciences | Initiates: Buy | $13 | $1.95 | +566.67% | 1 | Feb 2, 2026 | |
| CLLS Cellectis | Initiates: Buy | $9 | $4.18 | +115.31% | 1 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $22 → $47 | $14.54 | +223.25% | 2 | Dec 9, 2025 | |
| ANNX Annexon | Initiates: Buy | $17 | $5.09 | +233.99% | 1 | Dec 2, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $100 | $51.87 | +92.79% | 1 | Sep 17, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $190 | $272.50 | -30.28% | 1 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Downgrades: Hold | $45 | $55.20 | -18.48% | 1 | Jun 27, 2025 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $2.59 | +479.15% | 2 | May 10, 2024 | |
| FATE Fate Therapeutics | Maintains: Buy | $11 → $9 | $1.48 | +508.11% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $63 → $67 | $32.16 | +108.33% | 3 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $91 → $106 | $51.37 | +106.35% | 3 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $2.18 | +1,000.92% | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $5.73 | +947.12% | 1 | Feb 21, 2024 |
Korro Bio
Feb 19, 2026
Upgrades: Buy
Price Target: $10 → $18
Current: $12.14
Upside: +48.27%
Caribou Biosciences
Feb 2, 2026
Initiates: Buy
Price Target: $13
Current: $1.95
Upside: +566.67%
Cellectis
Dec 23, 2025
Initiates: Buy
Price Target: $9
Current: $4.18
Upside: +115.31%
Wave Life Sciences
Dec 9, 2025
Maintains: Buy
Price Target: $22 → $47
Current: $14.54
Upside: +223.25%
Annexon
Dec 2, 2025
Initiates: Buy
Price Target: $17
Current: $5.09
Upside: +233.99%
Dianthus Therapeutics
Sep 17, 2025
Initiates: Buy
Price Target: $100
Current: $51.87
Upside: +92.79%
Krystal Biotech
Jul 1, 2025
Initiates: Buy
Price Target: $190
Current: $272.50
Upside: -30.28%
CRISPR Therapeutics AG
Jun 27, 2025
Downgrades: Hold
Price Target: $45
Current: $55.20
Upside: -18.48%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.59
Upside: +479.15%
Fate Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.48
Upside: +508.11%
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $32.16
Upside: +108.33%
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $51.37
Upside: +106.35%
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $2.18
Upside: +1,000.92%
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $5.73
Upside: +947.12%